Skip to main content

Cisatracurium Besylate

NDC 31722-313 · Camber Pharmaceuticals Inc.

Generic nameCisatracurium Besylate
Dosage formINJECTION
RouteINTRAVENOUS
Active ingredient(s)CISATRACURIUM BESYLATE
Strength2 mg/mL
Pharmacologic classNeuromuscular Nondepolarizing Blockade [PE], Nondepolarizing Neuromuscular Blocker [EPC]
Marketing categoryANDA

Packages

31722-313-10 — 10 VIAL, SINGLE-DOSE in 1 CARTON (31722-313-10) / 5 mL in 1 VIAL, SINGLE-DOSE (31722-313-02)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

0143-9160 — Cisatracurium Besylate, 0143-9396 — Cisatracurium Besylate, 0143-9397 — Cisatracurium Besylate, 0409-1098 — CISATRACURIUM BESYLATE, 0409-1103 — CISATRACURIUM BESYLATE, 0409-1208 — CISATRACURIUM BESYLATE, 0781-3150 — cisatracurium besylate, 0781-3152 — cisatracurium besylate, 0781-3153 — cisatracurium besylate, 31722-312 — Cisatracurium Besylate, 31722-314 — Cisatracurium Besylate, 55150-284 — Cisatracurium Besylate, 55150-286 — Cisatracurium Besylate, 63323-416 — CISATRACURIUM BESYLATE, 63323-417 — CISATRACURIUM BESYLATE, 63323-418 — CISATRACURIUM BESYLATE, 65145-135 — Cisatracurium besylate, 65145-136 — Cisatracurium besylate, 65145-137 — Cisatracurium besylate, 68083-486 — Cisatracurium besylate, +17 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.